PANIPACproject (@PANIPAC) header
PANIPACproject (@PANIPAC) profile picture

The Era-NET Euronanomed III project PANIPAC combines innovative approaches in nanomedicine to generate an impact in the treatment of pancreatic cancer

Joined July 2019
Photo by PANIPACproject (@PANIPAC)
"Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen" clincancerres.aacrjournals.o…
Jacks Lab (@LabJacks) researchers led by Dr. Tyler Jacks and collaborators demonstrated that the CD155/TIGIT axis is critical in maintaining immune evasion in #pancreatic adenocarcinoma. 📍 bit.ly/2VAdJnO
2
1
Who will respond to immunotherapy? This recent paper suggests that the tumor microenvironment falls into 4 categories and can predict therapeutic response: bit.ly/3wQDcXR #AcademicTwitter @MDAndersonNews @BostonGeneCorp
1
18
43
PANIPACproject retweeted
Amazing new publication on a human colorectal cancer-on-chip model to study the microenvironmental influence on early metastatic spread pubmed.ncbi.nlm.nih.gov/3411… #microfluidics #colorectalcancer #organonchip #bodyonchip
3
5
Researchers show the importance of a dynamic synergistic relationship between patient cells with stromal fibroblasts, in a 3D perfused #vascular network, to accurately recapitulate a dynamic tumor microenvironment. 📌 bit.ly/2Tnnx3r
1
1
Let's make sure that everyone with #PancreaticCancer gets the tablets they need to build strength for treatment and improve the quality of their life. We're calling on the NHS to set and meet prescription targets. 💊 Sign today. pancreaticcancer.org.uk/tran… #TransformLivesPrescribe
1
16
3
26
Thanks to the brilliant work of all our collaborators, we will soon be publishing ‘Pancreatic enzyme replacement therapy in patients with pancreatic cancer’ - #PERT is a key component of #pancreaticcancer care but we are not doing enough to provide it to our patients yet!
2
25
8
53
Researchers 👩‍🔬👨‍🔬 evaluate the synergistic combination of #gemcitabine and #Zebularine in #pancreatic cancer cells. bit.ly/3vJIyU5
2
3
I am extremely happy to have had the opportunity to present DIVERSA at the DEMO day @LaconNetwork #STARTUPCONGRESSGALICIA DIVERSA. One technology, limitless applications. Let's start the therapeutic revolution. Follow #DIVERSA here to keep updated 👇🏻 lnkd.in/eve3spk
Pitch de María de la Fuente Freire de DIVERSA para el #DemoDay del #STARTUPCONGRESSGALICIA
2
7
22
Researchers developed patient-derived xenograft models of #pancreas which could be used as a preclinical tool to better understand the biology of #PancreaticCancers and its underlying impact on effectiveness of therapeutic approaches. 📗 @SciReports go.nature.com/3hD9hgU
2
5
Pancreatic Cancer May Succumb to “Dual Cell” Approach #Pancreaticcancer could be overcome by SLC7A11-silencing treatments that target both cancer cells and cancer-associated fibroblasts. Learn more: ow.ly/QqY550EMJZ2
6
12
⚠️ Just now on line Manipulating macrophage polarization in cancer patients: from nanoparticles to human chimeric antigen receptor macrophages – at Bologna, Emilia Romagna
2
2
Scientists identify the PAR1‐Myc axis as a driver of ductal cell fates in premalignant #pancreas and pancreatic ductal #adenocarcinoma. bit.ly/33jLv0X
Did you know that Pancreatic Cancer has the lowest survival rate of all cancers? Check out the data of different european countries: pancreaticcancereurope.eu/en…
2
1